Commentary: Management Strategies for POSEIDON Groups 3 and 4
- PMID: 32038485
- PMCID: PMC6992565
- DOI: 10.3389/fendo.2019.00920
Commentary: Management Strategies for POSEIDON Groups 3 and 4
Keywords: GnRH analog; POR; POSEIDON IV; Rec-FSH; adjuvants; classification; gonadotrophins; rec-LH.
Comment on
-
Management Strategies for POSEIDON Groups 3 and 4.Front Endocrinol (Lausanne). 2019 Sep 11;10:614. doi: 10.3389/fendo.2019.00614. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31572298 Free PMC article. Review.
References
-
- Alviggi C, Conforti A, Santi D, Esteves SC, Andersen CY, Humaidan P, et al. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis. Hum Reprod Update. (2018) 24:599–614. 10.1093/humupd/dmy019 - DOI - PubMed
-
- Blumenauer V, Czeromin U, Fehr D, Fiedler K, et al. DIR annual 2017. J Reproduktionsmed Endokrinol. (2018) 15:216–49.
Publication types
LinkOut - more resources
Full Text Sources
